Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 574
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07762508 A Prospective Single-Arm Study of VABu Conditioning Regimen in Allo-HSC… |
Venetoclax | Cancer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | National Cancer Institute (NCI) | China · First Affiliated Hospital of Soochow Universi… | 2026-08 → 2029-07 | Ouvrir |
| NCT07763756 Single vs Multiple Injection Intertransverse Process Block in Breast Ca… |
Multiple Level Intertransverse Pr… | Cancer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Antalya City Hospital | Non communiqué | 2026-11-01 → 2027-09-01 | Ouvrir |
| NCT07008027 Real World Asparaginase Therapy Toxicity |
Real World Asparaginase Therapy T… | Cancer | À vérifier | NOT_YET_RECRUITING | En attente / non publié | St. Jude Children's Research Hosp… | United States · St. Jude Children's Research Hospital… | 2026-09 → 2031-07 | Ouvrir |
| NCT04431024 Prospective Evaluation of High Resolution Dual Energy Computed Tomograp… |
Prospective Evaluation of High Re… | Cancer | À vérifier | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2021-03-30 → 2038-06-30 | Ouvrir |
| NCT00068003 Harvesting Cells for Experimental Cancer Treatments |
Anti-CD19 CAR PBL | Cancer | À vérifier | ENROLLING_BY_INVITATION | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2003-09-08 | Ouvrir |
| NCT05534386 A Self-management Based Survivorship Intervention for Chinese Cancer Su… |
A Self-management Based Survivors… | Cancer | Non applicable | RECRUITING | En attente / non publié | The University of Hong Kong | Hong Kong · Kwong Wah Hospital-Breast Center, Hong Ko… | 2023-04-12 → 2027-12-31 | Ouvrir |
| NCT05562518 GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRo… |
Estrogen | Cancer | Phase 4 | COMPLETED | En attente / non publié | University Hospital, Ghent | Belgium · University Hospital Ghent, Ghent, Belgium | 2022-03-21 → 2026-03-02 | Ouvrir |
| NCT04267848 Testing the Addition of a Type of Drug Called Immunotherapy to the Usua… |
Biospecimen Collection | Cancer | Phase 3 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States, Guam · Abbott-Northwestern Hospital, M… | 2020-06-16 → 2027-01-31 | Ouvrir |
| NCT05848557 mSaada: A Mobile Health Tool |
mSaada: A Mobile Health Tool | Cancer | Non applicable | RECRUITING | En attente / non publié | Duke University | Kenya · Kenya Medical Research Institute, Kisumu, Ken… | 2024-02-19 → 2027-06-30 | Ouvrir |
| NCT05679518 Managing Fear of Cancer Progression Metacognition-based Vs Supportive-e… |
Managing Fear of Cancer Progressi… | Cancer | Non applicable | RECRUITING | En attente / non publié | The University of Hong Kong | Hong Kong · Queen Mary Hospital-Department of Obstetr… | 2023-12-20 → 2027-06-30 | Ouvrir |
| NCT06995898 The Vanguard Study: Testing a New Way to Screen for Cancer |
Biospecimen Collection | Cancer | Non applicable | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · Cancer Care and Hematology-Fort Colli… | 2025-06-18 → 2029-06-30 | Ouvrir |
| NCT06524544 A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govi… |
Biospecimen Collection | Cancer | Phase 3 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · Abbott-Northwestern Hospital, Minneap… | 2025-12-02 → 2028-12-31 | Ouvrir |
| NCT07251582 LungTime-C02 — Effect of Infusion Timing on Pathologic Response to Neoa… |
LungTime-C02 — Effect of Infusion… | Cancer | Phase 3 | RECRUITING | En attente / non publié | Hunan Province Tumor Hospital | China · Hunan Cancer Hospital, Changsha, China | Hunn… | 2026-08-12 → 2029-05-31 | Ouvrir |
| NCT07154290 A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075… |
Ubamatamab | Cancer | Phase 2 | RECRUITING | En attente / non publié | Regeneron Pharmaceuticals | United States · Baylor Scott & White Health, Temple, … | 2026-03-18 → 2030-06-10 | Ouvrir |
| NCT07756840 Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respirat… |
PRGN-2012 | Cancer | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2026-08-18 → 2030-07-01 | Ouvrir |
| NCT04465214 Mobile Sensor Technologies to Assess General Symptomology of People Wit… |
Mobile Sensor Technologies to Ass… | Cancer | À vérifier | COMPLETED | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2020-11-23 → 2024-04-10 | Ouvrir |
| NCT05621291 A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testin… |
A Multicenter Study to Evaluate N… | Cancer | Non applicable | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · Children's Healthcare of Atlanta, Atl… | 2026-08-18 → 2027-12-31 | Ouvrir |
| NCT07678229 BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Auto… |
GELAD regimen | Cancer | Phase 3 | RECRUITING | En attente / non publié | Rong Tao | China · Fudan University Shanghai Cancer Center,, Sha… | 2026-08-11 → 2031-12-31 | Ouvrir |
| NCT06952504 A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination Wit… |
Pembrolizumab | Parkinson | Phase 3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Australia, Austria, Belgium… | 2025-05-22 → 2032-05-24 | Ouvrir |
| NCT06049212 TroFuse-008 — Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in C… |
Sacituzumab Tirumotecan | Parkinson | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | Japan · Aichi Cancer Center ( Site 0006), Nagoya, Jap… | 2023-10-26 → 2027-01-29 | Ouvrir |
| NCT06841354 A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy an… |
Sacituzumab Tirumotecan | Parkinson | Phase 3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Australia, Belgium, Brazil,… | 2025-03-16 → 2030-05-18 | Ouvrir |
| NCT07075627 A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eato… |
A Study to Evaluate the Incidence… | Myasthénie | À vérifier | WITHDRAWN | En attente / non publié | Addario Lung Cancer Medical Insti… | United States · Dana-Farber Cancer Institute, Boston,… | 2025-09 → 2026-12 | Ouvrir |
| NCT04990609 EUS-RFA PANCARDINAL-1 Trial |
Endoscopic Ultrasound (EUS)-Guide… | Cancer | Phase 2 | RECRUITING | En attente / non publié | The University of Texas Health Sc… | United States · Memorial Hermann Hospital, Houston, U… | 2021-08-13 → 2028-05-30 | Ouvrir |
| NCT05610852 Single-Port Transvesical Partial Prostatectomy Versus High Intensity Fo… |
Transvesical Single Port Robotic … | Cancer | Non applicable | RECRUITING | En attente / non publié | Case Comprehensive Cancer Center | United States · Glickman Urological & Kidney Institut… | 2024-01-01 → 2028-12-01 | Ouvrir |
| NCT00774436 Study of Focal Cryoablation in Low-Risk Prostate Cancer |
focal cryotherapy | Cancer | Phase 2 | COMPLETED | En attente / non publié | Memorial Sloan Kettering Cancer C… | United States · Memorial Sloan-Kettering Cancer Cente… | 2008-10-14 → 2019-07-23 | Ouvrir |